Literature DB >> 27113868

Understanding the adsorption of salmon calcitonin, antimicrobial peptide AP114 and polymyxin B onto lipid nanocapsules.

Anita Umerska1, Nada Matougui2, Anne-Claire Groo2, Patrick Saulnier2.   

Abstract

The adsorption of therapeutic molecules, e.g., peptides, onto nanocarriers is influenced by the properties of the carrier, adsorbed molecule and continuous phase. Hence, through changes in the composition of the nanocarrier and the medium, it should be possible to tune the system to make it capable of efficiently adsorbing peptides. The adsorption of calcitonin, antimicrobial peptide AP114 and polymyxin B onto lipid nanocapsules was investigated. The adsorption data were fitted to a Langmuir isotherm. Dynamic light scattering and laser Doppler velocimetry were used to investigate the changes in the hydrodynamic diameter and zeta potential, respectively, of the nanocarrier. The peptide adsorption was primarily governed by electrostatic forces; however, even without the presence of an ionisable surfactant, a significant amount of each tested molecule was adsorbed due to the enormous surface area of the nanocarriers and to peptide-nanocarrier interactions. The addition of an ionisable lipophilic surfactant, lecithin, improved the adsorption yield, which reached values of up to 100%. The adsorption yield and the properties of the nanocarrier, particularly the zeta potential, depended on the carrier and peptide concentrations and their mixing ratio. The adsorption of all tested molecules obeyed the Langmuir model over a limited concentration range.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  AP114; Adsorption; Antimicrobial peptide; Calcitonin; Lipid nanocapsules; NZ2114; Nanoparticles; Peptide; Plectasin; Polymyxin B

Mesh:

Substances:

Year:  2016        PMID: 27113868     DOI: 10.1016/j.ijpharm.2016.04.028

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  10 in total

1.  Growth-incompetent monomers of human calcitonin lead to a noncanonical direct relationship between peptide concentration and aggregation lag time.

Authors:  Kian Kamgar-Parsi; Liu Hong; Akira Naito; Charles L Brooks; Ayyalusamy Ramamoorthy
Journal:  J Biol Chem       Date:  2017-07-24       Impact factor: 5.157

Review 2.  The dual interaction of antimicrobial peptides on bacteria and cancer cells; mechanism of action and therapeutic strategies of nanostructures.

Authors:  Atefeh Parchebafi; Farzaneh Tamanaee; Hassan Ehteram; Ejaz Ahmad; Hossein Nikzad; Hamed Haddad Kashani
Journal:  Microb Cell Fact       Date:  2022-06-18       Impact factor: 6.352

3.  ArtinM Grafted Phospholipid Nanoparticles for Enhancing Antibiotic Cellular Uptake Against Intracellular Infection.

Authors:  Tri Suciati; Safira Nafisa; Tantri Liris Nareswari; Meta Juniatik; Elin Julianti; Marlia Singgih Wibowo; Titah Yudhistira; Ihsanawati Ihsanawati; Yani Triyani; Khairurrijal Khairurrijal
Journal:  Int J Nanomedicine       Date:  2020-11-10

Review 4.  Antimicrobial Peptides: An Emerging Category of Therapeutic Agents.

Authors:  Margit Mahlapuu; Joakim Håkansson; Lovisa Ringstad; Camilla Björn
Journal:  Front Cell Infect Microbiol       Date:  2016-12-27       Impact factor: 5.293

5.  Synergistic interactions between antimicrobial peptides derived from plectasin and lipid nanocapsules containing monolaurin as a cosurfactant against Staphylococcus aureus.

Authors:  Anita Umerska; Viviane Cassisa; Guillaume Bastiat; Nada Matougui; Hassan Nehme; Florence Manero; Matthieu Eveillard; Patrick Saulnier
Journal:  Int J Nanomedicine       Date:  2017-08-08

6.  Antibacterial activity of antipsychotic agents, their association with lipid nanocapsules and its impact on the properties of the nanocarriers and on antibacterial activity.

Authors:  Hassan Nehme; Patrick Saulnier; Alyaa A Ramadan; Viviane Cassisa; Catherine Guillet; Matthieu Eveillard; Anita Umerska
Journal:  PLoS One       Date:  2018-01-03       Impact factor: 3.240

7.  Surface active properties of lipid nanocapsules.

Authors:  Celia R A Mouzouvi; Anita Umerska; André K Bigot; Patrick Saulnier
Journal:  PLoS One       Date:  2017-08-10       Impact factor: 3.240

8.  Characterization of the in vitro, ex vivo, and in vivo Efficacy of the Antimicrobial Peptide DPK-060 Used for Topical Treatment.

Authors:  Joakim Håkansson; Lovisa Ringstad; Anita Umerska; Jenny Johansson; Therese Andersson; Lukas Boge; René T Rozenbaum; Prashant K Sharma; Petter Tollbäck; Camilla Björn; Patrick Saulnier; Margit Mahlapuu
Journal:  Front Cell Infect Microbiol       Date:  2019-05-28       Impact factor: 5.293

9.  Characterization of Biological Material Adsorption to the Surface of Nanoparticles without a Prior Separation Step: a Case Study of Glioblastoma-Targeting Peptide and Lipid Nanocapsules.

Authors:  Claire Gazaille; Marion Sicot; Marthe Akiki; Nolwenn Lautram; Aurélien Dupont; Patrick Saulnier; Joël Eyer; Guillaume Bastiat
Journal:  Pharm Res       Date:  2021-04-07       Impact factor: 4.200

10.  Structural Characterization Study of a Lipid Nanocapsule Formulation Intended for Drug Delivery Applications Using Small-Angle Scattering Techniques.

Authors:  Dileep Urimi; Maja Hellsing; Najet Mahmoudi; Christopher Söderberg; Ronja Widenbring; Lars Gedda; Katarina Edwards; Thorsteinn Loftsson; Nicolaas Schipper
Journal:  Mol Pharm       Date:  2022-02-28       Impact factor: 4.939

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.